Email us

CKD and Laboratory Practice

Acute Humoral Rejection in Kidney Transplantation – Morphology, Immunopathology, and Pathologic Classification

Antibodies in the Prevention of Renal Allograft Rejection

CKD – Where Clinical Medicine Meets Clinical Anatomy

Guideline for the laboratory diagnosis of functional iron deficiency

Guidelines for the diagnosis and management of disseminated intravascular coagulation

Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis


Henoch Scholein Purpura (HSP)

Managing Renal Anaemia

Methodology of screening for albuminuria

Molecular Pathogenesis of ADKPD and Therapeutic Options

NTN and Glomerulonephritis – Animal Model vs. Human Disease

Point of Care Testing

What I tell my patients about blood and urine tests

A breakthrough in diabetic nephropathy – The role of Endothelial Dysfunction

Advantage of ATG in renal Tx (NDT)

Chemoattraction of T-cells

Comparison between Creatinine and Cystatin C-based GFR equations

Does urinary tract infection cause proteinuria or microalbuminuria

EGFR rate as an end point in Kidney Tx Trial – Where do we Stand

Evaluation of tests for microalbuminuria screening

Expression of the chemokine receptor CXCR3 in human renal

Glomerular filtration rate—what is the rationale and justification

Laboratory assessment of immune function in renal transplant patients

Structural alterations to the podocyte are related to proteinuria in Type II Diabetic Patients

What does adequate dialysis dosing mean in the elderly mean

Your Results may Vary – The Imprecision of Medical Measurements

What does adequate dialysis dosing mean in the elderly mean

Using Smart Phone Technology to engage with young people with CKD

Understanding the Role of Health Information in Patients – German Study

The need to address poor numeracy skills in the emergency department environment.

Serum 1,25-dihydroxyvitamin D Better Reflects Renal Parameters Than 25-hydoxyvitamin D in Patients with Glomerular Disease

Renal POCT – A Collaboration between BMSs and Community Pharmacists

Referral and Management Options for CKD Patients

Presentation of laboratory test results in patient portals

Point-of-care creatinine testing


Patient Portals and Barriers

Patient Perceptions of Receiving Test Results – Online

Patient kidney disease knowledge

Methods for evaluation medical tests and biomarkers

Managing inappropriate utilization of laboratory resources

Managing Demand for Laboratory Tests

LabTests Online 2016 paper

Laboratory assessment of immune function in renal transplant patients

Kidney disease health literacy among new patients

Kidney Disease and mHealth

Impact of a Phone App on Nephrology Referral

How do laboratory specialists advise clinicians concerning the use and interpretation of renal tests

Gruson D. Paper 1,25 OHD 1-84 PTH and FGF23 in heart failure mortality

FGF23 induces left ventricular hypertrophy
FGF23 in Chronic Kidney Disease and ESRD_ Regulator of phosphorus balance, or much more than that_
FGF23 – parathyroid interaction – implications in CKD
Feasibility of point-of-care creatinine testing in community pharmacy to monitor drug therapy in ambulatory elderly patients
Exploring the prevalence of and factors associated with advice on prescription medicines
Electronic Consultation as an alternative to hospital referral for patients with CKD
Direct Release of Test Results to Patients Increases Patient Engagementa nd Utilization of Care
Diagnostic Uncertainty
Decimal numbers and safe interpretation of clinical pathology results
Cystatin C versus Creatinine in Determining Risk Based on Kidney Function
Creatinine point-of-care testing in Primary Care
Comparison between Creatinine and Cystatin C-based GFR equations
Clinical Utility and Cost Impact of Using Cystatin C
Clinical Significance of FGF23 in Patients with CKD